+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Microbiome Therapeutics Market by Products (Fecal Microbiota Transplantation, Live-Biotherapeutics, Microbiome Drugs), Therapeutic Area (Autoimmune Diseases, Cancer, Gastrointestinal Disorders), Formulation, Source, End-use, Distribution Channel - Global Forecast 2025-2030- Product Image
Microbiome Therapeutics Market by Products (Fecal Microbiota Transplantation, Live-Biotherapeutics, Microbiome Drugs), Therapeutic Area (Autoimmune Diseases, Cancer, Gastrointestinal Disorders), Formulation, Source, End-use, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Microbiome Therapeutics Market by Products (Fecal Microbiota Transplantation, Live-Biotherapeutics, Microbiome Drugs), Therapeutic Area (Autoimmune Diseases, Cancer, Gastrointestinal Disorders), Formulation, Source, End-use, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674221
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The microbiome therapeutics market is undergoing accelerated change as scientific advancements and new clinical applications foster a competitive environment for innovative healthcare solutions. Industry leadership now depends on integrating cross-disciplinary expertise, strategic partnerships, and rigorous market assessment to navigate emerging challenges and capture untapped potential in this expanding field.

Market Snapshot: Microbiome Therapeutics Market Overview

The Microbiome Therapeutics Market grew from USD 1.11 billion in 2024 to USD 1.27 billion in 2025. It is expected to continue growing at a CAGR of 14.65%, reaching USD 2.54 billion by 2030. This growth is fueled by innovation in live-biotherapeutics, rapid developments in genomics, and expanding applications across multiple disease indications. As new trade measures, regulatory frameworks, and global partnerships evolve, business leaders are seeking actionable insights and comprehensive analysis to make informed strategic decisions in this dynamic sector.

Scope & Segmentation

This report provides a detailed exploration of the microbiome therapeutics market, spanning a diverse array of products, therapeutic areas, formulations, sources, end-users, and distribution models. Each segment presents distinct growth opportunities and operational considerations:

  • Products: Fecal microbiota transplantation, live-biotherapeutics, microbiome drugs, microbiome ecosystem therapies, probiotics, and prebiotics.
  • Therapeutic Areas: Autoimmune diseases, cancer, gastrointestinal disorders, infectious diseases, metabolic disorders, neurological disorders.
  • Formulation: Oral and topical delivery approaches.
  • Source: Animal microbiome, environmental microbiome, human microbiome.
  • End-Use Settings: Academic and research institutions, hospitals and clinics.
  • Distribution Channels: Hospital pharmacies, retail pharmacies, online pharmacies.
  • Regional Coverage: Americas, Europe, Middle East and Africa, Asia-Pacific, including key national sub-segments such as the United States, Canada, China, and India.
  • Leading Companies: Coverage includes Alveolus Bio (ResBiotic), AOBiome, Assembly Biosciences, Axial Therapeutics, BioGaia, BiomeBank, EnteroBiotix, Enterome, Ferring, Intralytix, Kanvas Biosciences, Locus Biosciences, MaaT Pharma, Microba Life Sciences, Microbiotica, MRM Health, NuBiyota, Osel, Pendulum Therapeutics, PharmaBiome, Pylum Biosciences, Seres Therapeutics, Servatus, Siolta Therapeutics, Theriva Biologics, Vedanta Biosciences, Viome Life Sciences (BlueDot), and Xbiome.

Key Takeaways for Senior Decision-Makers

  • Advances in analytical technologies and bioinformatics are supporting the development of more targeted and multifaceted microbiome-based therapies, enabling creative therapeutic approaches that move beyond traditional probiotics and prebiotics.
  • Industry collaborations, especially between academic centers and biotech firms, are accelerating product innovation, validation, and translation from research to market, enabling personalized approaches and faster adoption.
  • Adaptation to evolving regulatory frameworks is essential, with organizations increasingly investing in compliance expertise and early dialogue to ensure smooth product progression and access in diverse jurisdictions.
  • Manufacturing strategies are shifting toward resilience and geographic diversification, as firms seek to address supply chain disruption risks and support sustainable global expansion.
  • Digital health integrations—such as remote monitoring, data-driven patient engagement, and telemedicine—enhance trial efficiency, evidence generation, and patient adherence across regions.
  • Expanding therapeutic indications highlight the versatility and scalability of microbiome interventions in areas ranging from neurology to oncology, positioning organizations to capture value across new clinical frontiers.

Tariff Impact: Navigating Trade Barriers and Industry Resilience

Recent tariff policies and trade adjustments have added complexity to supply chains, directly impacting sourcing costs for microbial strains, reagents, and specialized materials. Clinical operations have seen rising input costs, prompting organizations to evaluate strategies such as nearshoring, supply diversification, and domestic manufacturing investments. Legal and compliance teams must navigate intricate tariff classifications, as these trade measures often affect project timelines and budget planning. While present challenges may initially raise operational hurdles, they are fostering the emergence of more resilient and regionally distributed production ecosystems.

Methodology & Data Sources

The findings in this report combine in-depth primary research, including expert interviews and real-world stakeholder insights, with secondary analysis of academic publications, corporate filings, and regulatory documents. Key data are cross-verified using triangulation, market mapping, scenario planning, and competitiveness assessment to ensure objectivity, transparency, and actionable recommendations.

Why This Report Matters for Strategic Leadership

  • Equips senior leaders and market strategists with data-driven insights to guide investment, portfolio planning, and market entry.
  • Enables organizations to anticipate regulatory and trade shifts, fortify supply chains, and optimize competitive positioning in a changing landscape.
  • Supports proactive decision-making by detailing innovative pipelines, cross-sector partnerships, and commercial strategies tailored to evolving global opportunities.

Conclusion

In summary, this comprehensive analysis delivers a clear roadmap for navigating the microbiome therapeutics sector. Strategic segmentation, informed by current trends and actionable insights, empowers industry leaders to drive innovation and unlock lasting value across the healthcare continuum.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in targeted CRISPR-based microbiome editing for precision gut flora modulation
5.2. Rising investment in anaerobic spore-based therapeutics for recurrent Clostridioides difficile prevention
5.3. Development of live biotherapeutic consortiums to treat inflammatory bowel disease with defined microbial strains
5.4. Integration of multi-omics data and machine learning to identify personalized microbial biomarkers
5.5. Emergence of postbiotic and paraprobiotic formulations as stable alternatives to live microbial therapies
5.6. Evolving regulatory frameworks by FDA and EMA to accelerate approval of microbiome-based drugs
5.7. Strategic alliances between biotech innovators and pharmaceutical giants to commercialize next-generation microbiome therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Microbiome Therapeutics Market, by Products
8.1. Introduction
8.2. Fecal Microbiota Transplantation
8.3. Live-Biotherapeutics
8.4. Microbiome Drugs
8.5. Microbiome Ecosystem Therapies
8.6. Probiotics & Prebiotics
9. Microbiome Therapeutics Market, by Therapeutic Area
9.1. Introduction
9.2. Autoimmune Diseases
9.3. Cancer
9.4. Gastrointestinal Disorders
9.5. Infectious Diseases
9.6. Metabolic Disorders
9.7. Neurological Disorders
10. Microbiome Therapeutics Market, by Formulation
10.1. Introduction
10.2. Oral
10.3. Topical
11. Microbiome Therapeutics Market, by Source
11.1. Introduction
11.2. Animal Microbiome
11.3. Environmental Microbiome
11.4. Human Microbiome
12. Microbiome Therapeutics Market, by End-use
12.1. Introduction
12.2. Academic & Research Institutions
12.3. Hospitals & Clinics
13. Microbiome Therapeutics Market, by Distribution Channel
13.1. Introduction
13.2. Offline
13.2.1. Hospital Pharmacies
13.2.2. Retail Pharmacies
13.3. Online Pharmacies
14. Americas Microbiome Therapeutics Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Microbiome Therapeutics Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Microbiome Therapeutics Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Alveolus Bio, Inc. by ResBiotic
17.3.2. AOBiome LLC
17.3.3. Assembly Biosciences, Inc.
17.3.4. Axial Therapeutics, Inc.
17.3.5. BioGaia AB
17.3.6. BiomeBank
17.3.7. EnteroBiotix Ltd
17.3.8. Enterome SA
17.3.9. Ferring B.V.
17.3.10. Intralytix, Inc.
17.3.11. Kanvas Biosciences
17.3.12. Locus Biosciences, Inc.
17.3.13. MaaT Pharma SA
17.3.14. Microba Life Sciences Limited
17.3.15. Microbiotica Ltd.
17.3.16. MRM Health NV
17.3.17. NuBiyota
17.3.18. Osel, Inc.
17.3.19. Pendulum Therapeutics
17.3.20. PharmaBiome AG
17.3.21. Pylum Biosciences
17.3.22. Seres Therapeutics, Inc.
17.3.23. Servatus Limited
17.3.24. Siolta Therapeutics
17.3.25. Theriva Biologics, Inc.
17.3.26. Vedanta Biosciences, Inc.
17.3.27. Viome Life Sciences, Inc. by BlueDot LLC
17.3.28. Xbiome Co. Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. MICROBIOME THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. MICROBIOME THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. MICROBIOME THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. MICROBIOME THERAPEUTICS MARKET: RESEARCHAI
FIGURE 28. MICROBIOME THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 29. MICROBIOME THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 30. MICROBIOME THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MICROBIOME THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY LIVE-BIOTHERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY LIVE-BIOTHERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY MICROBIOME DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY MICROBIOME DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY MICROBIOME ECOSYSTEM THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY MICROBIOME ECOSYSTEM THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ANIMAL MICROBIOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ANIMAL MICROBIOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ENVIRONMENTAL MICROBIOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ENVIRONMENTAL MICROBIOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HUMAN MICROBIOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HUMAN MICROBIOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 99. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 100. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 101. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 102. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 103. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 104. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 105. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 106. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 107. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 108. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 109. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 112. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 113. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 114. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 115. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 116. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 117. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 185. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 186. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 187. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 188. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 189. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 190. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 191. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 192. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 193. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 194. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 195. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 198. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 199. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 200. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 201. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 202. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 203. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 204. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 205. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 206. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 207. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 208. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 209. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 212. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 227. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 228. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 229. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 230. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 231. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 232. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 233. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 234. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 235. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 236. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 237. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 240. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 241. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 242. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 243. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 244. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 245. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 246. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 247. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 248. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 249. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 250. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 251. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 254. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 297. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 298. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 299. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 300. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 301. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 302. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 303. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 304. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 305. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 306. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 307. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 310. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 325. QATAR MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
TABLE 326. QATAR MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025-2030 (USD MILLION)
TABLE 327. QATAR MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 328. QATAR MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 329. QATAR MICROBIOME

Samples

Loading
LOADING...

Companies Mentioned

  • Alveolus Bio, Inc. by ResBiotic
  • AOBiome LLC
  • Assembly Biosciences, Inc.
  • Axial Therapeutics, Inc.
  • BioGaia AB
  • BiomeBank
  • EnteroBiotix Ltd
  • Enterome SA
  • Ferring B.V.
  • Intralytix, Inc.
  • Kanvas Biosciences
  • Locus Biosciences, Inc.
  • MaaT Pharma SA
  • Microba Life Sciences Limited
  • Microbiotica Ltd.
  • MRM Health NV
  • NuBiyota
  • Osel, Inc.
  • Pendulum Therapeutics
  • PharmaBiome AG
  • Pylum Biosciences
  • Seres Therapeutics, Inc.
  • Servatus Limited
  • Siolta Therapeutics
  • Theriva Biologics, Inc.
  • Vedanta Biosciences, Inc.
  • Viome Life Sciences, Inc. by BlueDot LLC
  • Xbiome Co. Ltd.

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.27 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.54 Billion
Compound Annual Growth Rate14.6%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Human Microbiome Market by Product Type (Fecal Microbiota Transplant, Microbiome Sequencing Services, Postbiotics), Indication (Gastrointestinal Disorders, Infections, Metabolic Disorders), Application, End User - Global Forecast 2025-2030 - Product Image

Human Microbiome Market by Product Type (Fecal Microbiota Transplant, Microbiome Sequencing Services, Postbiotics), Indication (Gastrointestinal Disorders, Infections, Metabolic Disorders), Application, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Microbiome Diagnostics Market by Technology (Microarray, Next-Gen Sequencing, Qpcr), Diagnostic Application (Disease Diagnosis, Drug Development, Personalized Nutrition), Sample Type, Indication, End User, Service Type, Component - Global Forecast 2025-2030 - Product Image

Microbiome Diagnostics Market by Technology (Microarray, Next-Gen Sequencing, Qpcr), Diagnostic Application (Disease Diagnosis, Drug Development, Personalized Nutrition), Sample Type, Indication, End User, Service Type, Component - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Live Biotherapeutic Products and Microbiome CDMO Market Size, Share & Trends Analysis Report by Application (C. Difficile, Crohn's Disease, IBS, Diabetes), Region (North America, Europe, APAC, MEA) with Growth Forecasts, 2025-2030 - Product Image

Live Biotherapeutic Products and Microbiome CDMO Market Size, Share & Trends Analysis Report by Application (C. Difficile, Crohn's Disease, IBS, Diabetes), Region (North America, Europe, APAC, MEA) with Growth Forecasts, 2025-2030

  • Report
  • 137 Pages
  • Global
From
Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics), Diseases (Infectious, Gastrointestinal, Endocrine & Metabolic), Type (BCT/FMT, Live Biotherapeutics), End User (Hospitals, Clinics, Long-Term Care) - Global Forecast to 2030 - Product Image

Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics), Diseases (Infectious, Gastrointestinal, Endocrine & Metabolic), Type (BCT/FMT, Live Biotherapeutics), End User (Hospitals, Clinics, Long-Term Care) - Global Forecast to 2030

  • Report
  • 291 Pages
  • Global
From
Live Biotherapeutic Products and Microbiome CDMO - Global Strategic Business Report - Product Image

Live Biotherapeutic Products and Microbiome CDMO - Global Strategic Business Report

  • Report
  • 108 Pages
  • Global
From

About the Microbiome Market

The Microbiome market is a subset of the biotechnology industry that focuses on the study of microbial communities and their interactions with the environment. It is a rapidly growing field, with research and development activities focusing on the development of new products and services that can be used to improve human health and the environment. Microbiome-based products and services are used in a variety of industries, including pharmaceuticals, food and beverage, agriculture, and cosmetics. The Microbiome market is driven by the increasing demand for personalized medicine, as well as the need for more efficient and cost-effective treatments for various diseases. Additionally, the development of new technologies, such as next-generation sequencing and metagenomics, has enabled researchers to better understand the composition and function of microbial communities. Companies in the Microbiome market include Second Genome, uBiome, Seres Therapeutics, and Enterome Bioscience. These companies are focused on developing products and services that can be used to improve human health and the environment. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.